Locoid is owned by Bausch.
Locoid contains Hydrocortisone Butyrate.
Locoid has a total of 2 drug patents out of which 0 drug patents have expired.
Locoid was authorised for market use on 18 May, 2007.
Locoid is available in lotion;topical dosage forms.
The generics of Locoid are possible to be released after 19 December, 2026.
|Patent Number||Company||Patent Title||Patent Expiry||Activity Alert|
|These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).|
|US7981877||BAUSCH||Stabilized steroid composition and method for its preparation|| |
(1 year, 7 months from now)
|US7378405||BAUSCH||Stabilized steroid composition and method for its preparation|| |
(3 years from now)
Drugs and Companies using HYDROCORTISONE BUTYRATE ingredient
Market Authorisation Date: 18 May, 2007
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic